<DOC>
	<DOCNO>NCT00986687</DOCNO>
	<brief_summary>Vitrification method cryopreserve biological specimen sensitive chill injury oocyte embryos , employ increase survival rate live birth ( Hong et al. , 1999 ; Kuleshova et al. , 1999 ; Yoon et al. , 2000 ; Chung et al 2000 ; Wu et al. , 2001 : Kuwayama et al 2006 ) . In study researcher propose directly compare oocyte survival , fertilizaton embryo development sibling oocyte . The Cryotop method vitrification , researcher aim investigate study , report efficient method human oocytes cryopreservation ( Kuwayama et al , 2005 , Antinori et al , 2006 , Lucena et al , 2006 , Cobo et al , 2008 ) . Follow 200 infant conceive vitrified oocyte ( Chian et al , 2008 ) indicate mean birth weight incidence congenital anomaly comparable spontaneous conception fertile woman infertile woman undergo IVF treatment .</brief_summary>
	<brief_title>Oocyte Cryopreservation Comparing Fresh Vitrified Sibling Oocytes</brief_title>
	<detailed_description>The necessity cryopreserve human oocytes successfully , goal achieve term pregnancy rate equivalent obtain fresh oocyte urgent . Cryopreservation oocytes desirable : 1 ) would allow infertility patient store excess oocyte instead embryos , eliminate ethical religious concern accompany embryo storage ; 2 ) permit storage donor oocytes egg bank , analogous exist sperm bank . This option would allow cryopreserved oocyte quarantine screen infectious disease complete , would also avoid donor-recipient synchronization difficulty ; 3 ) help cancer patient preserve fertility face sterilization due chemotherapy radiation . Oocyte cryopreservation therefore gain popularity option infertility treatment well fertility preservation . This pilot study evaluate outcome oocyte vitrification use Cryotop method woman undergo IVF , simultaneously evaluate embryo derive vitrified fresh oocyte come stimulated cycle . The primary outcome measure track tabulated oocyte survival , fertilization cleavage rate , subsequent embryo development , compare vitrified fresh oocyte . Secondary outcome implantation , clinical pregnancy , miscarriage live birth rate use embryos derive vitrified oocyte transfer .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>1 . Females 21 37 year age . 2 . Normal serum follicle stimulate hormone ( FSH ) concentration &lt; 10 mIU/ml estradiol ( E2 ) concentration &lt; 70 pg/ml obtain day # 2 3 menstrual cycle . 3 . BMI &lt; 35 . 4 . No physical gynecological abnormality ( include major uterine surgery ) constitute medical contraindication embryo transfer pregnancy include know significant genetic disorder 5 . Nonsmoker least 3 month prior study enrollment . 6 . Normal antral follicle count ( total â‰¥ 10 ) . 1 . Greater 1 previous miscarriage . 2 . More 1 previous fail IVF attempt . 3 . Previous poor response ovarian stimulation ( peak E2 level &lt; 1,000 pg/ml &lt; 4 oocyte retrieve ) . 4 . Presence untreated hydrosalpinx . 5 . Stage III IV endometriosis . 6 . Intent preimplantation genetic diagnosis ( PGD ) embryos 7 . Unwillingness freeze inseminate eligible oocyte embryos . 8 . Male partner require surgical sperm retrieval ( MESA TESA ) .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Oocyte cryopreservation</keyword>
	<keyword>vitrification</keyword>
</DOC>